Mohamed Fares (Metwaly)

Lecturer

University of Sydney

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Mohamed Fares Metwaly is a Lecturer at the University of Sydney, Australia. His research focuses on the development of novel inhibitors for carbonic anhydrases and the exploration of metal complexes in cancer therapy. Recent publications highlight his work on triazole-grafted benzenesulfonamides and their effects on colorectal cancer cells, as well as innovative approaches in anion receptor chemistry.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

A series of fluorescent coumarin-based bis-ureas have been synthesised. These compounds show strong HCl cotransport properties in model vesicle systems. Cellular localisation studies show that cytotoxic compound 4 localises in lysosomes and perturbs cellular pH.

Year:

2023

Year:

2023

Year:

2023

Collaborators (4)

Philip A. Gale

University of Sydney

AUSTRALIA

View details

Stephen Loeb

Professor and Canada Research Chair

University of Windsor

CANADA

View details

Deep Jyoti Bhuyan

Research Fellow (Lecturer)

AUSTRALIA

View details

Pere Fontova

Assistant Professor

University of Barcelona

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mohamed Fares (Metwaly)

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Shooting an Arrow against Convulsion: Novel Triazole-Grafted Benzenesulfonamide Derivatives as Carbonic Anhydrase II and VII Inhibitors

Platinum-based metal complexes as chloride transporters that trigger apoptosis

4-(Pyrazolyl)benzenesulfonamide Ureas as Carbonic Anhydrases Inhibitors and Hypoxia-Mediated Chemo-Sensitizing Agents in Colorectal Cancer Cells

Discovery of new sulfonamide-tethered 2-aryl-4-anilinoquinazolines as the first-in-class dual carbonic anhydrase and EGFR inhibitors.

The postbiotic sodium butyrate synergizes the antiproliferative effects of dexamethasone against the AGS gastric adenocarcinoma cells.

Furazan bis-ureas: a heterocyclic scaffold for anion binding and transport

Platinum-based metal complexes as chloride transporters that trigger apoptosis.

A potent fluorescent transmembrane HCl transporter perturbs cellular pH and promotes cancer cell death

Design and synthesis of 6-arylpyridine-tethered sulfonamides as novel selective inhibitors of carbonic anhydrase IX with promising antitumor features toward the human colorectal cancer

New insights and discoveries in anion receptor chemistry

Collaborators (4)

Philip A. Gale

Stephen Loeb

Deep Jyoti Bhuyan

Pere Fontova

Make your next move.